logo
ScreenersREIT EarningsREIT SectorsMarketplaceLearn
Logo

Dyadic International, Inc.

DYAI

Dyadic International, Inc., a biotechnology platform company, develops, produces, and sells enzymes and other proteins in the United States. The company utilizes its patented and proprietary C1 platform and other technologies to conduct research, development, and commercial activities for the development and manufacturing of human and animal vaccines and drugs, such as virus like particles and antā€¦ read more

Healthcare

Biotechnology

15 years

USD

Exclusive to Premium users

Price

per share adjusted in USD

$0.75

Price

-6.46%

-$0.05

$0.80

Previous Close

$0.79

Open

Premium

52w Discount
Market Cap

$27.022m

Small

Price/Earnings

-

Premium

3y Avg

Premium

5y Avg

Financials Overview

Key metrics over the past few years

-

EBITDA Margin

-

Net Profit Margin

-

Free Cash Flow Margin
Revenue

$3.554m

-

1y CAGR

-

3y CAGR

-

5y CAGR
Earnings

-$5.827m

-

1y CAGR

-

3y CAGR

-

5y CAGR
EPS

-$0.20

-

1y CAGR

-

3y CAGR

-

5y CAGR
Book Value

$923.610k

$7.895m

Assets

$6.971m

Liabilities

$5.065m

Debt
Debt to Assets

64.2%

-0.6x

Debt to EBITDA
Free Cash Flow

-$4.812m

-

1y CAGR

-

3y CAGR

-

5y CAGR

Financial Reports

Earnings and other important metrics. Amounts in USD.
No items found.
Press Releases
Statements and updates from the company
ā†‘ TopSummaryPriceFinancialsPress Releases
logo
About usFAQ
All the information presented is collected from official and public documents such as: Quarterly and Annual Reports, 10-K (US), Information Form (Canada), Presentations and the Investor Relations (IR) section of the company's website.
The data displayed by alreits.com is solely for informational purposes, we do not recommend the buying, holding or selling of any of the stocks on the website. If you have no experience in the stock market, please talk to your personal licensed investment advisor before making any decisions.